Osborne Clarke

The broad and ‘extremely competent’ offering at Osborne Clarke often assists clients which are active within the medtech and pharma industries, particularly in relation to rare diseases. Thomas Devred leads the team, and is well equipped to advise on licensing, market access, and supply chain issues, in addition to handling data privacy issues involving patient data. Regulatory expert Léa Masson-Boukobza often acts for medical device and pharma clients in matters involving anti-gift rules, advertising, and clinical trials.